IW Seed Fund
ALung Technologies, Inc.
ALung has developed the Hemolung™, an extracorporeal artificial lung that will replace or supplement the ventilator in the ICU for acute respiratory failure. The Hemolung will provide 50% of a patient’s respiratory need, allowing the lungs to heal, eliminating the need for intubation, sedation and mechanical ventilation. The Hemolung™ will reduce the incidence of ventilator associated pneumonia and hospital length of stay, resulting in a reduced cost of care for these patients. The Company has completed animal and human trials and expects initiate commercialization in Europe in Q1 2013.
Emergence Dental is a research and development-stage medical device company taking a dental-first approach to emerging new regenerative products from metallic magnesium alloys, that safely resorb when implanted in the body.
Lumis is a cutting-edge technology company that aims to disrupt the traditional clinical and healthcare training experience by making it more immersive, accessible, and efficient. Our augmented reality and data-driven InSight Platform provides training across the healthcare education spectrum to ensure that the same quality of training can be received by anyone, at any time, and anywhere.
RE2, Inc. is a leading developer of Intelligent Modular Manipulation Systems. RE2’s goal is to advance the state of the art of mobile manipulation and develop technologies that benefit robot users in the defense, public safety, and other markets. RE2 is developing mobile manipulation systems that are stronger, more dexterous, more versatile, more intuitive, smarter, and more affordable. RE2’s development efforts are focused on creating interoperable manipulation systems, intuitive human robot interfaces, and advanced autonomy software for mobile robotics.